Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07853742) titled 'Omadacycline for Treatment Refractory Mycoplasma Genitalium Urethritis' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Montefiore Medical Center
Condition:
Mycoplasma Genitalium Infection
Urethritis
Intervention:
Drug: Omadacycline Oral Tablet
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2026
Target Sample Size: 10
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07853742
Discl...